Quintiles invests in Kareus

CRO Quintiles Transnational Corp. (Research Triangle Park, N.C.) will make an equity investment in Kareus Therapeutics S.A. (La Chaux-de-Fonds, Switzerland) and provide clinical support to develop Kareus' two preclinical programs for Alzheimer's disease and diabetes. Quintiles will make a seven-figure investment in Kareus, one-third of which will comprise an equity investment and the remainder comprising access to Quintiles' clinical services on a shared-risk basis. ...